À propos de l'instructeur :
Dr. Passakorn Wanchaijiraboon is a Medical Oncologist and Vice Director of Phrapokklao Hospital for AI and Medical Innovation. He serves as Secretary of the AI Committee of the Medical Council of Thailand, where he plays a central role in drafting the national guidelines on artificial intelligence ethics for medical practitioners. His areas of expertise span clinical oncology, AI governance in healthcare, medical device regulation, and digital health policy.
He has been actively involved in developing policy frameworks that integrate international AI ethics standards — including those from WHO, AMA, US FDA, and the EU AI Act — into the Thai medical regulatory context. Dr. Passakorn is committed to ensuring that AI technologies in medicine are deployed safely, ethically, and with the physician remaining at the center of clinical decision-making.
Résumé du séminaire
As artificial intelligence rapidly transforms medical practice — from diagnostic imaging and genomic analysis to clinical documentation and drug prescribing — the need for clear ethical guardrails has become urgent. This presentation introduces the proposed Medical Council of Thailand announcement on AI ethics guidelines for medical practitioners, developed with reference to international frameworks from the WHO, AMA, US FDA, the EU AI Act, IMDRF, and the FUTURE-AI Consortium, as well as Thailand's NSTDA AI Ethics Principles. The guidelines are structured around seven core ethical principles: privacy, security and safety, reliability, fairness and non-discrimination, transparency and explainability, accountability, and human oversight.
A key practical component is the Medical AI Risk Assessment (MAIRA) — adapted from the UK Camden Council's AI Risk Assessment (AIRA) framework — which provides a structured, lifecycle-based checklist for healthcare organizations to evaluate AI systems before clinical deployment. Covering five stages from overall assessment, planning, training and testing, review, through to deployment and post-market monitoring, the MAIRA ensures that physicians remain the final decision-makers while leveraging AI as a tool for augmented — not autonomous — clinical intelligence. Real-world case studies illustrate the practical application of these principles in Thai healthcare settings.
Séminaires connexes
